莱斯康制药(LXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LXRX 莱斯康制药

交易中 10-19 11:15:45 EDT

1.55

+0.03

+1.64%

最高1.57	最低1.52	成交量48.30万
今开1.54	昨收1.52	日振幅3.29%
总市值6.86亿	流通市值3.41亿	总股本4.44亿
成交额74.19万	换手率0.22%	流通股本2.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LXRX","market":"US","secType":"STK","nameCN":"莱斯康制药","latestPrice":1.545,"timestamp":1792422936431,"preClose":1.52,"halted":0,"volume":483030,"delay":0,"changeRate":0.01644736842105257,"floatShares":220415134,"shares":444000000,"eps":-0.158737,"marketStatus":"交易中","change":0.025,"latestTime":"10-19 11:15:45 EDT","open":1.54,"high":1.565,"low":1.515,"amount":741943.933812,"amplitude":0.032895,"askPrice":1.55,"askSize":2380,"bidPrice":1.54,"bidSize":2929,"shortable":3,"etf":0,"ttmEps":-0.158737,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1792440000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":955080000000,"exchange":"NASDAQ","adjPreClose":1.52,"preHourTrading":{"tag":"盘前","latestPrice":1.56,"preClose":1.52,"latestTime":"09:26 EDT","volume":5535,"amount":8995.1482395,"timestamp":1792416360053,"change":0.04,"changeRate":0.026316,"amplitude":0.106579},"postHourTrading":{"tag":"盘后","latestPrice":1.59,"preClose":1.52,"latestTime":"19:46 EDT","volume":11554,"amount":17822.7,"timestamp":1792194380816,"change":0.07,"changeRate":0.046053,"amplitude":0.046053},"volumeRatio":0.941897,"impliedVol":0.8519,"impliedVolPercentile":0.3386},"requestUrl":"/m/hq/s/LXRX","defaultTab":"news","newsList":[{"id":"1113304905","title":"莱斯康制药已从诺和诺德获得7500万美元里程碑付款，潜在总额达10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113304905","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113304905?lang=zh_cn&edition=full","pubTime":"2026-08-24 20:31","pubTimestamp":1787574681,"startTime":"0","endTime":"0","summary":"莱斯康制药（Lexicon Pharmaceuticals）宣布，已从诺和诺德（Novo Nordisk）处获得7500万美元的里程碑付款。这笔款项是其潜在总额高达10亿美元的里程碑付款计划中的一部分。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193224349","title":"莱斯康制药有望获得高达10亿美元的首付款、里程碑付款及特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1193224349","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193224349?lang=zh_cn&edition=full","pubTime":"2026-08-24 20:31","pubTimestamp":1787574674,"startTime":"0","endTime":"0","summary":"莱斯康制药（Lexicon Pharmaceuticals）在最新公布的消息中披露，该公司将有资格获得一笔可观的财务回报——总额最高可达10亿美元的资金支持。这笔资金构成颇具层次感，涵盖首付款、关键里程碑节点的阶段性付款，以及基于未来销售的特许权使用费。多重收益机制的叠加，无疑为这家生物制药企业的资金链注入了强劲的想象空间。值得注意的是，这一数字背后折射出的，是市场对其在研管线潜力的认可，抑或是合作方对其商业化前景的押注——无论哪种解读，都值得投资者密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143875587","title":"莱斯康制药达成关键一期临床里程碑，获诺和诺德第三笔1000万美元里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1143875587","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143875587?lang=zh_cn&edition=full","pubTime":"2026-08-24 20:31","pubTimestamp":1787574671,"startTime":"0","endTime":"0","summary":"莱斯康制药宣布，已达成Lx9851药物的关键一期开发里程碑，从而从诺和诺德获得第三笔1000万美元的里程碑付款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193695599","title":"莱斯康制药拟向售股股东发行至多125.7856万股普通股——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1193695599","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193695599?lang=zh_cn&edition=full","pubTime":"2026-08-07 05:10","pubTimestamp":1786050620,"startTime":"0","endTime":"0","summary":"莱斯康制药（Lexicon Pharmaceuticals）在向美国证券交易委员会（SEC）提交的文件中明确表示，计划将高达125.7856万股普通股向售股股东进行发行。这一举措，瞬间引发了市场对于其股权结构及未来资金流向的广泛关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164058552","title":"莱斯康制药获得18个月先息后本贷款安排 含两次六个月展期选项","url":"https://stock-news.laohu8.com/highlight/detail?id=1164058552","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164058552?lang=zh_cn&edition=full","pubTime":"2026-05-05 04:10","pubTimestamp":1777925456,"startTime":"0","endTime":"0","summary":"生物制药企业莱斯康制药（Lexicon Pharmaceuticals）近日宣布与海格投资（Hercules Capital）达成一项创新型贷款协议。该融资方案最引人注目的特点是设置了长达18个月的先息后本期，在此期间企业仅需支付利息，无需偿还本金。\n根据协议条款，在初始18个月期限届满后，莱斯康制药还享有两次为期六个月的展期选择权。这种灵活的安排为企业提供了充足的现金流缓冲空间，使其能够更专注于核心药物研发业务的推进。\n此项融资安排体现了投资机构对莱斯康制药研发管线价值的认可。通过优化债务结构，企业得以在保持研发投入的同时有效管理财务风险，为未来业务拓展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4139","BK4135","BK4007","HTGC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518522222","title":"莱斯康制药盘中异动 早盘急速下挫5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518522222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518522222?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613563,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，莱斯康制药股票出现波动，股价大幅跳水5.56%。截至发稿，该股报0.370美元/股，成交量48.2552万股，换手率0.13%，振幅5.10%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.18%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213243abf2fc93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213243abf2fc93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518897552","title":"莱斯康制药2024财年实现净利润-2.00亿美元，同比减少12.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518897552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518897552?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536075,"startTime":"0","endTime":"0","summary":"3月10日，莱斯康制药公布财报，公告显示公司2024财年净利润为-2.00亿美元，同比减少12.99%；其中营业收入为31.08百万美元，同比增加2490.00%，每股基本收益为-0.63美元。从资产负债表来看，莱斯康制药总负债1.52亿美元，其中短期债务1.18百万美元，资产负债比为1.97，流动比率为0.06。机构评级：截至2025年3月10日，当前有4家机构对莱斯康制药目标价做出预测，其中目标均价为2.95美元，其中最低目标价为0.80美元，最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000235a268986e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000235a268986e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2517613251","title":"莱斯康制药盘中异动 早盘大幅上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517613251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517613251?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:48","pubTimestamp":1741272507,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时48分，莱斯康制药股票出现异动，股价快速拉升5.15%。截至发稿，该股报0.353美元/股，成交量98.0654万股，换手率0.27%，振幅7.08%。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，43%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224827963c50db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224827963c50db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2517599941","title":"莱斯康制药盘中异动 快速上涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517599941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517599941?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:55","pubTimestamp":1741190111,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时55分，莱斯康制药股票出现波动，股价快速上涨5.51%。截至发稿，该股报0.343美元/股，成交量228.905万股，换手率0.63%，振幅9.24%。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，43%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体涨幅为1.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235511989d59d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235511989d59d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677697","title":"莱斯康制药盘中异动 早盘大幅上涨9.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677697?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:35","pubTimestamp":1741098902,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时35分，莱斯康制药股票出现波动，股价快速拉升9.02%。截至发稿，该股报0.319美元/股，成交量131.072万股，换手率0.36%，振幅7.66%。机构评级方面，在所有7家参与评级的机构中，71%的券商给予买入建议，29%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.11%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223502a25f05b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223502a25f05b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516363427","title":"莱斯康制药股价重挫39.37% 市值跌6035.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516363427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516363427?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012346,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分，莱斯康制药股票出现异动，股价急速跳水39.37%。截至发稿，该股报0.424美元/股，成交量1659.15万股，换手率4.59%，振幅8.28%。最近的财报数据显示，该股实现营业收入1.75百万美元，净利润-64.81百万美元，每股收益-0.18美元，毛利1.55百万美元，市盈率-0.57倍。机构评级方面，在所有7家参与评级的机构中，71%的券商给予买入建议，29%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223226a25d4002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223226a25d4002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2516304301","title":"莱斯康制药盘中异动 急速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516304301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516304301?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:48","pubTimestamp":1740775689,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时48分，莱斯康制药股票出现异动，股价快速拉升5.42%。截至发稿，该股报0.706美元/股，成交量168.908万股，换手率0.47%，振幅7.55%。机构评级方面，在所有7家参与评级的机构中，71%的券商给予买入建议，29%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.78%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301044810a2585520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301044810a2585520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514433037","title":"莱斯康制药盘中异动 临近收盘股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514433037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514433037?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:52","pubTimestamp":1740689557,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时52分，莱斯康制药股票出现异动，股价快速下跌5.18%。截至发稿，该股报0.670美元/股，成交量142.115万股，换手率0.39%，振幅7.77%。机构评级方面，在所有7家参与评级的机构中，71%的券商给予买入建议，29%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022804523798955550&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022804523798955550&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514590748","title":"莱斯康制药盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514590748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514590748?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:50","pubTimestamp":1740581440,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时50分，莱斯康制药股票出现异动，股价急速拉升5.11%。截至发稿，该股报0.689美元/股，成交量36.5912万股，换手率0.10%，振幅2.29%。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为4190.61%、150.19%、118.93%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Renovaro Inc.，振幅分别为127.12%、38.41%、29.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225041abddf1ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225041abddf1ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514015326","title":"莱斯康制药盘中异动 大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514015326?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:06","pubTimestamp":1740495989,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时06分，莱斯康制药股票出现异动，股价大幅下跌5.00%。截至发稿，该股报0.667美元/股，成交量130.533万股，换手率0.36%，振幅5.34%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Lava Therapeutics N.V.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1022.33%、579.28%、515.58%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nutriband Inc C/Wts ，振幅分别为47.10%、43.70%、42.76%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230629a2538fbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230629a2538fbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512136165","title":"莱斯康制药股价上涨11.72% 市值涨3715.16万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512136165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512136165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889127,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，莱斯康制药股票出现波动，股价急速上涨11.72%。截至发稿，该股报0.877美元/股，成交量59.9228万股，换手率0.17%，振幅2.26%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为276.09%、91.01%、60.62%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Allakos Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为8.57%、8.35%、6.13%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223207a24aacb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223207a24aacb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511696242","title":"莱斯康制药盘中异动 早盘急速上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511696242?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:32","pubTimestamp":1739543562,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时32分，莱斯康制药股票出现波动，股价快速拉升5.22%。截至发稿，该股报0.780美元/股，成交量5.0061万股，换手率0.01%，振幅1.34%。机构评级方面，在所有7家参与评级的机构中，71%的券商给予买入建议，29%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223242abcf06ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223242abcf06ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511805521","title":"莱斯康制药盘中异动 早盘快速拉升5.04%报0.730美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511805521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511805521?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:19","pubTimestamp":1739459987,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时19分，莱斯康制药股票出现波动，股价快速上涨5.04%。截至发稿，该股报0.730美元/股，成交量25.5442万股，换手率0.07%，振幅3.77%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Edesa Biotech, Inc.、Enanta Pharmaceuticals, Inc.、Nutriband Inc C/Wts 涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为1931.73%、1125.23%、148.83%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为92.30%、73.65%、40.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213231948988435df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213231948988435df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510336834","title":"莱斯康制药盘中异动 股价大跌5.03%报0.713美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510336834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510336834?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:38","pubTimestamp":1739288298,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时38分，莱斯康制药股票出现异动，股价快速下跌5.03%。截至发稿，该股报0.713美元/股，成交量40.7065万股，换手率0.11%，振幅4.89%。莱斯康制药股票所在的生物技术行业中，整体跌幅为1.84%。其相关个股中，Ocean Biomedical, Inc.、In8Bio, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2689.13%、1055.35%、366.64%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、37.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211233818961f5490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211233818961f5490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.lexpharma.com","stockEarnings":[{"period":"1week","weight":-0.0952},{"period":"1month","weight":-0.2475},{"period":"3month","weight":-0.364},{"period":"6month","weight":-0.1872},{"period":"1year","weight":0.034},{"period":"ytd","weight":0.3217}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lexicon Pharmaceuticals, Inc.是一家生物制药公司，专注于研究并实现人类疾病在治疗上的突破。通过基因敲除技术和先进的医疗技术综合平台，该公司已经系统研究了小白鼠体内近5000个基因的生理和行为功能，且评估了由相应的人类基因作为潜在药物靶标所编码的蛋白质的效用，并且已经在活体（或活的有机体）内确定并验证了100多个能很好地应用于药物发现的靶标。对于那些被认定有很高药用价值的靶标，其致力于对潜在新药物的研制计划。该公司于1995年7月7日在美国特拉华州成立，并于1995年9月开始营运。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.040884},{"month":2,"riseRate":0.423077,"avgChangeRate":-0.046623},{"month":3,"riseRate":0.5,"avgChangeRate":-0.016324},{"month":4,"riseRate":0.461538,"avgChangeRate":0.013505},{"month":5,"riseRate":0.518519,"avgChangeRate":0.041126},{"month":6,"riseRate":0.666667,"avgChangeRate":0.133521},{"month":7,"riseRate":0.481481,"avgChangeRate":0.019303},{"month":8,"riseRate":0.259259,"avgChangeRate":-0.025305},{"month":9,"riseRate":0.333333,"avgChangeRate":0.004544},{"month":10,"riseRate":0.518519,"avgChangeRate":-0.013253},{"month":11,"riseRate":0.384615,"avgChangeRate":-0.041818},{"month":12,"riseRate":0.461538,"avgChangeRate":0.062158}],"exchange":"NASDAQ","name":"莱斯康制药","nameEN":"Lexicon Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱斯康制药(LXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱斯康制药(LXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱斯康制药,LXRX,莱斯康制药股票,莱斯康制药股票老虎,莱斯康制药股票老虎国际,莱斯康制药行情,莱斯康制药股票行情,莱斯康制药股价,莱斯康制药股市,莱斯康制药股票价格,莱斯康制药股票交易,莱斯康制药股票购买,莱斯康制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱斯康制药(LXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱斯康制药(LXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}